NASDAQ:PTGX - Protagonist Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$12.30 +0.12 (+0.99 %)
(As of 03/19/2019 10:39 AM ET)
Previous Close$12.18
Today's Range$12.11 - $12.63
52-Week Range$5.49 - $21.26
Volume38,797 shs
Average Volume142,085 shs
Market Capitalization$287.21 million
P/E Ratio-7.07
Dividend YieldN/A
Beta2.05

Analyst Ratings

Protagonist Therapeutics (NASDAQ:PTGX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Protagonist Therapeutics in the last 12 months. Their average twelve-month price target is $17.25, suggesting that the stock has a possible upside of 40.24%. The high price target for PTGX is $21.00 and the low price target for PTGX is $13.00. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.602.602.50
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $17.25$16.25$19.40$21.00
Price Target Upside: 40.24% upside138.97% upside185.29% upside103.29% upside

Protagonist Therapeutics (NASDAQ:PTGX) Consensus Price Target History

Price Target History for Protagonist Therapeutics (NASDAQ:PTGX)

Protagonist Therapeutics (NASDAQ:PTGX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/22/2019BMO Capital MarketsInitiated CoverageOutperform$17.00MediumView Rating Details
12/6/2018NomuraInitiated CoverageBuy ➝ Buy$13.00LowView Rating Details
8/6/2018Leerink SwannBoost Price TargetOutperform$13.00 ➝ $21.00HighView Rating Details
6/6/2018BarclaysDowngradeOverweight ➝ Equal Weight$18.00LowView Rating Details
3/26/2018Stifel NicolausDowngradeBuy ➝ HoldMediumView Rating Details
7/21/2017BTIG ResearchInitiated CoverageBuy ➝ Buy$36.00MediumView Rating Details
(Data available from 3/19/2017 forward)
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Featured Article: Discount Rate

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel